Patent details

EP1007055 Title: USE OF AMIFOSTINE

Basic Information

Publication number:
EP1007055
PCT Application Number:
PCT/US/1998/003614
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP989066881
PCT Publication Number:
WO/1998/034622
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF AMIFOSTINE
French Title of Invention:
UTILISATION D'AMIFOSTINE
German Title of Invention:
VERWENDUNG VON AMIFOSTIN
SPC Number:

Dates

Filing date:
11/02/1998
Grant date:
04/02/2004
EP Publication Date:
04/02/2004
PCT Publication Date:
13/08/1998
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2000
EP B1 Publication Date:
04/02/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/02/2011
Expiration date:
11/02/2018
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/06/2004
 
 

Name:
MedImmune Oncology Inc.
Address:
One MedImmune Way, Gaitherburg, MD 20878, United States (US)

Agent

Name:
WAXWEILER Jean
From:
28/05/2004
Address:
PO Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

1

Name:
SCHEIN Philip, S.
Address:
United States (US)

2

Name:
STOGNIEW Martin
Address:
United States (US)

Priority

Priority Number:
798840
Priority Date:
12/02/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/66;
Filing date Document type Number of pages